Company ProfilePremium

Supreme Petrochem Ltd.

Company Profile Analysis

Ticker: SPLPETRO.NS

ESOMAR 23 Corporate BadgeISO Certifications Badge
Supreme Petrochem Ltd. - Company showcase

Year Founded & Workforce

1989

444 Employees

Supreme Petrochem Ltd. logo

Supreme Petrochem Ltd. Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Supreme Petrochem Ltd. Overview

Supreme Petrochem is India's dominant producer of styrenic polymers, with more than 50% domestic share in polystyrene (PS) and expandable polystyrene (EPS). It operates the country's only extruded polystyrene (XPS) insulation-board plant and, since September 2025, India's first continuous mass-ABS line (70,000 TPA, licensed from Versalis/Eni). The company is a joint venture of two Mumbai business families: the Taparias (The Supreme Industries, India's largest plastics processor) and the Rajan Raheja group. It converts imported styrene monomer into PS, EPS, ABS, compounds, masterbatches and XPS at a single integrated complex at Amdoshi (Raigad, Maharashtra) and an EPS plant in Chennai. It also trades styrene monomer, which supplied about 20% of FY26 turnover. Earnings follow the styrene–polymer spread cycle. The balance sheet has no borrowings, ₹874 cr of investable surplus (June 2026) and a 60% payout policy in practice. The strategy is to move the mix from commodity PS/EPS toward engineering plastics (ABS, compounds) and building insulation while defending scale leadership against imports.


What the company does. SPL is a downstream petrochemical manufacturer in the styrenics value chain. It does not produce styrene monomer (SM) itself, which is in structural deficit in India. Instead it imports SM, mainly from the Middle East, Singapore and East Asia, and polymerises it into:

  • general-purpose and high-impact polystyrene (GPPS, HIPS);

  • expandable polystyrene beads (EPS, sold to moulders who make "thermocol");

  • mass acrylonitrile-butadiene-styrene (ABS);

  • specialty polymer compounds (SPC) and masterbatches based on styrenics, PP and nylon;

  • XPS rigid insulation boards.

It also resells imported SM to domestic users, a lower-margin trading activity.

The company's own description. In its FY26 BRSR and investor decks, SPL describes itself as primarily a B2B supplier serving original equipment manufacturers (OEMs) and a broad range of manufacturers. Named end uses include:

  • air-conditioner, refrigerator and washing-machine OEMs;

  • air-cooler and geyser housings, household goods, cutlery, dairy packaging, TV and computer parts, stationery and imitation jewellery;

  • protective packaging for electricals;

  • fisheries, produce and pharmaceutical packaging;

  • blocks and sheets for false ceilings.

The investor deck calls the Amdoshi site "India's first truly international scale state-of-art Styrenics complex" and claims market leadership in PS and EPS with a share above 50%.

Revenue model. SPL earns essentially all of its revenue from product sales. It has no subscription, licensing or service income.

Pricing is not publicly disclosed product by product. Commentary from management and CRISIL shows that polymer prices track international SM and polymer benchmarks, so profitability is driven by the "delta" (spread) between SM and finished polymer rather than by absolute price. The Q1 FY27 call cited GPPS deltas widening by about US$200/t and HIPS by US$300–400/t. Raw-material inventory of 30–40 days, plus 4–6 weeks of material in transit (CRISIL), creates inventory gains when prices rise and losses when they fall.

Value-chain position. The chain runs: crude/naphtha → benzene + ethylene → styrene monomer (imported) → SPL polymerisation → converters and moulders (injection moulding, thermoforming, EPS moulding, compounding) → OEMs and end markets. Promoter Supreme Industries is itself a downstream converter, and related-party sales were 2.42% of SPL's sales in FY26 (BRSR).

Customer types and channels.

  • Sales are mostly direct.

  • Dealers and distributors handled 11% of sales in FY26 (8% in FY25), through 14 distributors; the top 10 accounted for 98% of distributor sales (BRSR).

  • The customer base is split between OEMs and non-OEM processors (CRISIL). The non-OEM segment is the more price-elastic: it cut purchases sharply when SM prices spiked in Q1 FY27.

  • Customers are in about 100 countries.

  • SPL holds Three Star Export House status, valid to 31 March 2028.

End markets served.

Independent characterisation. SPL is a spread-driven, import-substituting converter with near-monopoly domestic scale in PS. That status was reinforced in FY2021 when the second-largest producer's plant (LG Polymers, Visakhapatnam) shut after the May 2020 styrene leak. CRISIL notes that the second-largest player's plant closed in FY2021. SPL's moat rests on four things: scale; logistics proximity to West-India appliance clusters; a long-standing grade portfolio designed to counter low-priced imports; and conservative finances. Its weaknesses are total dependence on imported SM, heavy exposure to the Indian cooling-appliance cycle, and a historically thin specialty mix (SPC and XPS were about 6% of FY25 revenue, per CRISIL). The ABS, compounding (Xmold) and XPS expansions are the first credible move up the value curve, but execution in FY26 was uneven: ABS started six months late and then halted for an equipment failure.

Strategy

Stated strategic themes (Annual Report FY26, investor decks, earnings calls; paraphrased).

  1. Defend leadership in PS and EPS through scale, quality and grades designed against imports. Market share is above 50%.

  2. Diversify into higher-value engineering plastics (mass ABS, ABS-based compounds) to lift the through-cycle margin and reduce PS cyclicality.

  3. Grow value-added downstream: specialty compounds, masterbatches and XPS insulation, aimed at OEM, auto and building-energy-efficiency demand.

  4. Expand geographically within India: South (Xmold, Manali) and North (Karnal greenfield).

  5. Remain debt-free and fund all capex from internal accruals and liquid surplus.

  6. Pursue sustainability: about 50% renewable power, zero liquid discharge at both plants, post-consumer EPS/PS recycling with ICPE and NGOs, and EPR compliance.

Initiatives in the last 24 months.

Medium-term financial targets and guidance.

FY26 (given early FY26): about 10% volume growth, made up of 3–4% from the base business and 6–7% from ABS. Actual growth was 2%.

FY27: an earlier 8–10% volume growth figure was conditional on market normalcy by end-June 2026. On the Q1 FY27 call (July 2026), management declined to give volume or margin guidance because of West Asia uncertainty and called the Q1 margin of about 19% an aberration.

CRISIL base case: 4–6% annual volume growth in the base business, a steady-state operating margin of about 7%, and liquid surplus of ₹400–500 cr.

India Ratings: the outlook depends on reaching sustained EBITDA of INR 5.5–6.0 bn.

  • No formal ROE or margin targets are published by the company.

Products & Services

All products are sold B2B. Specific grade names and price lists are not publicly disclosed. Pricing follows market (spot or formula) terms linked to SM and international polymer benchmarks.

General Purpose Polystyrene (GPPS)

Description: Transparent amorphous styrene homopolymer for injection moulding and extrusion.

Key properties: High clarity and gloss, good dimensional stability, easy processing, FDA-compliant grades (Q1 FY27 deck). SPL follows EU 10/2011 and US FDA 21 CFR 176.17 food-contact standards (BRSR).

Target customers: Refrigerator-component moulders, stationery and writing-instrument makers, rigid-sheet extruders, medical-disposable and household-goods producers, bead and bangle makers.

Launch: Since 1995. Capacity is shared with HIPS (300,000 TPA).

Flagship role: Core volume product. India imported about 87,000 t of PS in FY26 (Q1 FY27 call), the main competing supply.

High Impact Polystyrene (HIPS)

Description: Rubber-modified, opaque PS with high impact strength and stiffness.

Properties: Wide processing window, balanced mechanicals, high flexural strength.

Target customers: Refrigerator cabinet and liner makers, AC and cooler body moulders, toy makers, computer-accessory producers, food and dairy packaging thermoformers.

Launch: Since 1995.

Note: HIPS deltas widened most sharply in Q1 FY27 (+US$300–400/t).

Expandable Polystyrene (EPS)

Description: PS beads impregnated with pentane that expand and fuse into foam ("thermocol").

Properties: Light weight, thermal insulation, cushioning, mouldable into any shape.

Target customers: Consumer-durable packaging moulders; fish and fruit packaging; cold-storage and building-insulation panel makers; helmet and infant car-seat producers; 3D construction panels; geofoam for road building.

Capacity: Amdoshi plus Manali (Chennai), about 33,000 TPA at Manali. EPS Phase II was completed in 2026, taking stated installed capacity to 143,000 TPA.

Launch: EPS since the 2000s (Amdoshi). The Chennai brownfield expansion was commissioned around November 2022.

Competitive note: New domestic EPS capacity, including Styrenix and EPACK per KRChoksey (FY25), intensifies competition.

Mass ABS (Acrylonitrile Butadiene Styrene)

Description: Opaque engineering thermoplastic made by continuous mass polymerisation. SPL describes this as a first in India. The technology is licensed from Versalis S.p.A., Italy (imported 2022, first line fully absorbed per AR FY26).

Claimed attributes versus emulsion ABS: Better lot-to-lot consistency, lower base colour and more efficient colouring, better UV and thermal stability, fewer gels, lower VOCs, higher melt strength. Customer benefits claimed include less scrap, lower pigment use, lower regrind, better surface finish, lower odour (vehicle interiors) and better thermoforming. The process is also cleaner, with no water-pollution stream from emulsion polymerisation.

Applications: Automotive sheet and components, e-scooters, small electrical devices, mixers and grinders, RO purifiers, coolers, refrigerators, toys, helmets, clocks, auto batteries, medical equipment and bathroom fittings.

Capacity: 70,000 TPA, commissioned 25 September 2025. Terminal nameplate after Phase II is 140,000 TPA. Total project cost for both phases is estimated at about ₹850 cr (PolymerUpdate).

Status: Halted in December 2025 for an equipment failure and restarted in February–March 2026. Management targets about 36,000 t of ABS volume in FY27, roughly 65% utilisation (pre-Q1 FY27 benchmark). No advance order book was taken; OEM approvals for ABS compounds began after sample matching (Q3 FY26 call).

Specialty Polymer Compounds (SPC)

Description: Ready-to-use custom grades with functional minerals and additives, formulated in GPPS, HIPS, SAN, ABS, PP and nylon.

Property families: - flame-retardant (electrical switch accessories, auto and industrial batteries);

  • UV-stabilised custom-colour (ACs, washing machines, TVs, water heaters, purifiers, kitchen appliances);

  • mineral- and glass-filled (auto exterior, interior and under-hood parts, blower and fan impellers, textile bobbins);

  • impact-modified, low-shrink, high-heat.

Target customers: Appliance and auto OEMs and their Tier-I/II moulders.

Capacity: Masterbatches and compounds 50,000 TPA at Amdoshi, expanding to 80,000 TPA (ABS compounding focus), plus Xmold's 15,000 TPA in Tamil Nadu.

Strategic role: Captive outlet for ABS. Xmold gives direct access to southern auto and appliance clusters (Chennai, Sri City) and laboratory capability.

Masterbatches

Description: Concentrates of colourants, specialty minerals and performance additives.

Functions: Lower material and energy cost; better colour, brightness and surface finish; resistance to UV and heat, blocking, static, fire and microbial fouling.

Product families: - White and additive masterbatches: dairy, edible oil and ghee, grain, cereal and juice packaging, medical, cosmetics, fertiliser and pesticide packaging.

  • Black masterbatches: pipes and films for agriculture and irrigation.

  • Colour masterbatches: appliances, auto parts, switch accessories, kitchenware, toys, stationery, geotextiles.

Extruded Polystyrene (XPS) insulation board — "INSUboard"

Description: Rigid closed-cell foam board made by fully automated continuous extrusion. SPL operates India's first and only XPS plant (company claim).

Properties: High compressive strength, high R-value, low water absorption.

Applications: Wall, roof and floor insulation for commercial and residential buildings; refrigerated vehicles; vaccine and medicine boxes; tunnel linings.

Capacity: 72,000 m³, expanding to 122,000 m³.

Strategic angle: Energy-efficiency building codes and cold chain.

Styrene Monomer (traded)

Description: Imported SM resold to domestic users. India is in SM deficit.

Scale: 19.76% of FY26 turnover (BRSR).

Margin profile: Low margin; dilutes blended margins (KRChoksey).

Other listed specialties

  • Exchange and aggregator profiles also list Styrene Methyl Methacrylate (SMMA) among SPL's products. No separate capacity or revenue is disclosed in the FY26 presentation.

Services

  • Technical support only: processing guidelines and troubleshooting guides for customers, and customer-satisfaction surveys every two years (BRSR). No standalone service revenue.

Financial Narrative

All figures are standalone, INR Mn, for fiscal years ending 31 March. Sources: AR FY26 ten-year Performance Highlights (lakh converted to Mn), the Q2 FY26 and Q1 FY27 presentations, and Stock Analysis/Stockopedia for cash flows and gross profit where the company is silent.

Income statement

Notes:

  • FY22 operating EBITDA is derived (total EBITDA minus other income).

  • Gross profit is the Stock Analysis computation (revenue minus cost of revenue on its revenue base). SPL does not report gross profit under Ind AS.

  • The FY26 exceptional item of INR 100 Mn includes INR 29 Mn booked in Q4. Its nature is not detailed in sources reviewed.

  • EPS for FY22 is on the post-split FV ₹2 basis (AR footnote).

  • FY22 and FY23 reported DPS include pre-split interim and final dividends on ₹4 shares (FY22: ₹4 interim + ₹14 final; FY23: ₹4 pre-split interim + ₹7 final). These are adjusted ÷2 for the pre-split components.

  • Consolidated FY26: total income INR 54,498 Mn, revenue from operations INR 54,063 Mn, PBT INR 4,481 Mn, PAT INR 3,299 Mn (AR FY26 Board's Report). Xmold therefore added roughly INR 680 Mn of revenue and about INR 26 Mn of PAT before eliminations (derived).

Margins and growth

Revenue CAGR.

  • FY2022–FY2026 (4 years): 1.5% per year (derived).

  • FY2021–FY2026 (5 years, from FY21 net sales of INR 31,852 Mn): 10.9% per year (derived).

Commentary.

FY22 was the cycle peak: Pandemic-era supply tightness and wide SM–PS deltas lifted the operating EBITDA margin to about 18% and ROANW to 51%. CRISIL confirms margins of 18–21% in FY21–FY22, against 3–10% before FY2020.

FY23–FY24 normalised: Revenue was flat at about INR 52.5–52.9 bn despite 13.7% volume growth in FY24, because SM fell more than 11% in FY24 (AR FY24). Margins compressed to below 9%.

FY25 was a volume year: Revenue rose 14.7% on higher prices and 9.4% volume growth. Margins held at 8.8%, but depreciation and finance costs (leases) rose as new capacity was capitalised.

FY26 was a trough with a sharp exit: Revenue fell 11.4% because average SM prices dropped about 17% while volume grew only 2%. Causes were unseasonal rains, a mild summer hitting AC and refrigerator demand, deferred purchases ahead of GST rate cuts on durables, tariff-driven trade-flow shifts, rising imports and destocking (AR FY26; Q2 FY26 deck).

The quarterly path was a V: Q3 bottomed at a 5.5% operating margin with ABS halted and SM falling. Q4 recovered to 16.0% as the West Asia war widened international deltas.

D&A rose 34% in FY26: as ABS and expansions were capitalised; the gross block roughly doubled (PPE from INR 6.9 bn to INR 13.6 bn).

Q1 FY27 was a record at the EBITDA level: Revenue was INR 16,927 Mn (+22% YoY) on 24.5% lower volume. Operating EBITDA was INR 3,305 Mn (19.53% margin) and PAT INR 2,363 Mn (+192%). Management itself calls the margin an "aberration" driven by global deltas rather than structural improvement.

Balance sheet — five-year summary

FY22–FY23 total assets are derived as net worth × (1 + TOL/NW). On "Borrowings", AR FY26 confirms no term loan was availed or used as at 31 March 2026, and the company describes itself as debt-free.

Balance sheet — detailed (company disclosure)

Source: Q1 FY27 presentation, Historical Standalone Balance Sheet. Consolidated goodwill on Xmold is not disclosed in sources reviewed. Company-reported net debt/equity was −0.55x (FY24), −0.40x (FY25) and −0.30x (FY26). India Ratings computed net leverage including LC acceptances at −0.7x for FY25. The difference from the derived net cash above arises because the company presentation's net-debt definition is not stated. Investable surplus was INR 5,220 Mn (September 2025), INR 4,630 Mn (December 2025, CRISIL) and INR 8,740 Mn (June 2026).

Commentary.

Investment absorbed liquidity in FY24–FY26: Liquid assets fell from INR 10.9 bn to INR 7.2 bn as roughly INR 9 bn of capex (ABS, EPS II, SPC) and about INR 5.3 bn of dividends were funded internally.

Working capital swung: Inventories jumped 46% in FY25 ahead of ABS start-up and a rising SM market, then normalised in FY26. Receivables rose 28% in FY26 as Q4 sales surged.

Liquidity rebuilt quickly: Investable surplus recovered to INR 8.7 bn by June 2026, helped by Q1 FY27 cash generation.

Cash flow

Sources: Stock Analysis / Stockopedia (annual-report-based). Capex is derived as OCF minus FCF. Dividends declared are derived from split-adjusted DPS × 188.04 Mn shares; FY26 matches the company's outflow disclosure (interim INR 470.1 Mn plus final INR 1,504.3 Mn = INR 1,974 Mn, a 60.32% payout per AR FY26). Financing cash flow consists mainly of dividends and lease payments.

Commentary.

  • Cash conversion weakened through FY25–FY26. OCF/EBITDA fell to about 44% in FY26 as receivables rose and margins compressed.

  • Cumulative FY24–FY26 free cash flow (INR 2.5 bn) did not cover cumulative dividends (INR 5.5 bn). The gap was bridged by drawing down treasury. This was deliberate under a self-funding policy, but it cannot repeat indefinitely if the ₹900 cr capex programme overlaps with another spread downturn.

  • CRISIL expects net cash accrual of ₹300–400 cr per year against capex of ₹200–300 cr (base case) and liquid surplus maintained at ₹400–500 cr.

Return, leverage and efficiency ratios

Sources: AR FY26 ten-year table (ROANW, ROACE). Payable days for FY25 and FY26 are from BRSR; FY24 is derived. CRISIL reports interest coverage of 53.24x (FY24) and 40.16x (FY25) and adjusted debt/net worth of 0.06x including leases. The difference from the coverage figures above reflects CRISIL's operating-profit basis.

Commentary.

  • Returns have reset from super-normal (FY22 ROE 51%) to mid-teens. The decline was compounded in FY26 by a large, not-yet-productive asset base: ABS ran for only about four of the twelve months.

  • The cash conversion cycle widened from about 2 to about 17 days, a modest but notable deterioration that Ind-Ra flagged ("rising net working capital").

  • ROIC stays well above any reasonable cost of capital. The near-term lever is ABS utilisation on a roughly doubled gross block.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Group Entities

EntityRelationshipStakeBusinessSource

Supreme Petrochem Ltd

Listed parent

—

Styrenics manufacture and SM trading

AR FY26

Xmold Polymers Pvt Ltd (Tamil Nadu)

Subsidiary (first, from April 2025)

80%; remaining 20% targeted by March 2027

15,000 TPA engineering polymer compounding plant at Gummidipoondi, near Chennai and Sri City; Tier-II supplier to auto and appliance OEMs

BRSR FY26; CRISIL

TP Saturn Ltd (Tata Power Renewable SPV)

Captive power SPV; SPL holds a minority equity stake (size not disclosed; part of non-current investments)

—

12.5 MW solar power supplied to Amdoshi under a Power Delivery Agreement

BRSR FY26; Q1 FY27 deck

“—” = not publicly disclosed.

Business Lines

Business lineFY2025FY2026

Manufactured products share of turnover (%)

77.080.24

Traded goods (mainly SM) share of turnover (%)

23.019.76

Manufactured products revenue (INR Mn, derived)

46,38042,835

Traded goods revenue (INR Mn, derived)

13,85410,549

Product Families

Product familyShare of FY2025 revenue

PS and EPS

71%

Specialty polymer compounds, masterbatches and XPS

6%

Traded goods (SM)

23%

ABS

0% (commissioned September 2025)

Operating Metrics (MT) and Segment Margins & Growth (%)

MetricFY2023FY2024FY2025FY2026

Sales volume, manufactured products (MT)

286,000325,235355,967363,203

YoY volume growth (%)

013.79.42.0

Results by Segment and Segment Margins & Growth (%)

MetricQ1FY26Q2FY26Q3FY26Q4FY26Q1FY27

Revenue from operations (INR Mn)

13,86511,00212,64715,87016,927

Operating EBITDA (INR Mn)

1,1477766932,5323,305

Operating EBITDA margin (%)

8.277.055.4815.9519.53

PAT (INR Mn)

8094823021,6802,363

Sales volume (MT)

93,85376,96291,713100,66470,842

Products

ProductInstalled capacityLocation

Polystyrene (GPPS + HIPS)

300,000 TPA; rising to 380,000 TPA by March 2029

Amdoshi

Mass ABS

70,000 TPA; Phase II to 140,000 TPA planned

Amdoshi

EPS

143,000 TPA (company total after EPS Phase II, including about 33,000 TPA at Manali)

Amdoshi + Manali

Masterbatches and compounds

50,000 TPA; expanding to 80,000 TPA

Amdoshi

XPS boards

72,000 m³; expanding to 122,000 m³

Amdoshi

Xmold compounding (subsidiary)

15,000 TPA

Gummidipoondi, Tamil Nadu

Income Statement and Per-Share Data

MetricFY2022FY2023FY2024FY2025FY2026

Revenue from operations (INR Mn)

50,32352,87252,53360,23453,384

Other income (INR Mn)

305589681732433

Gross profit, aggregator basis (INR Mn)

11,8419,8468,0638,9079,307

Operating EBITDA excl. other income (INR Mn)

9,0396,5824,6685,3255,148

Total EBITDA incl. other income (INR Mn)

9,3447,1715,3496,0585,581

Depreciation & amortisation (INR Mn)

419466595679911

Operating income, Op. EBITDA minus D&A (INR Mn)

8,6206,1164,0734,6464,237

Finance cost (INR Mn)

483672124141

Exceptional items (INR Mn)

0000-100

Profit before tax (INR Mn)

8,8786,6694,6825,2544,429

Tax expense (INR Mn)

2,2451,6881,2171,3491,156

Net profit / PAT (INR Mn)

6,6334,9813,4653,9053,273

EPS basic = diluted (INR)

35.2726.4918.4320.7717.41

Dividend per share as reported (INR)

18.0011.009.0010.0010.50

Dividend per share, split-adjusted to FV ₹2 (INR)

9.009.009.0010.0010.50

Margin Analysis (%)

MetricFY2022FY2023FY2024FY2025FY2026

Revenue growth YoY (%)

58.05.1-0.614.7-11.4

Gross margin, aggregator basis (%)

23.618.715.414.817.3

Operating EBITDA margin (%)

17.9612.458.898.849.64

Total EBITDA margin on revenue (%)

18.5713.5610.1810.0610.45

Operating (EBIT) margin (%)

17.1311.577.757.717.94

PBT margin (%)

17.6412.618.918.728.30

Net margin (%)

13.189.426.606.486.13

Effective tax rate (%)

25.325.326.025.726.1

PAT growth YoY (%)

38.9-24.9-30.412.7-16.2

Balance Sheet and Per-Share Data

MetricFY2022FY2023FY2024FY2025FY2026

Shareholders' funds / net worth (INR Mn)

15,15618,43920,19122,31323,702

Capital employed (INR Mn)

15,50018,79320,56522,71124,274

Total assets (INR Mn; FY22–FY23 derived)

22,43126,92130,64834,48134,667

Book value per share (INR)

8198107119126

Total outside liabilities / net worth (x)

0.480.460.500.530.44

Borrowings, short + long term (INR Mn)

00000

Balance Sheet

MetricFY2024FY2025FY2026

Property, plant & equipment (INR Mn)

6,5756,90713,581

Capital work-in-progress (INR Mn)

2,3265,808741

Right-of-use assets (INR Mn)

1,1101,2141,131

Intangible assets, standalone (INR Mn)

3916

Non-current investments incl. Xmold (INR Mn)

054374

Inventories (INR Mn)

4,8067,0086,143

Trade receivables (INR Mn)

3,9503,9325,038

Liquid mutual funds (INR Mn)

5,7184,3002,868

Cash & cash equivalents (INR Mn)

2,1593,0542,965

Other bank balances (INR Mn)

3,0451,5641,363

Total liquid assets (INR Mn, derived)

10,9228,9187,196

Trade payables (INR Mn)

8,0899,2777,863

Lease liabilities, current + non-current (INR Mn)

1,1421,2951,261

Net cash incl. leases as debt (INR Mn, derived)

9,7807,6235,935

Current assets (INR Mn)

20,02720,21318,662

Current liabilities (INR Mn)

8,98710,6109,261

Working capital (INR Mn, derived)

11,0409,6039,401

Total equity (INR Mn)

20,19122,31323,702

Total assets (INR Mn)

30,64834,48134,667

Cash Flow

MetricFY2022FY2023FY2024FY2025FY2026

Operating cash flow (INR Mn)

6,7073,0365,5703,4162,465

Capital expenditure (INR Mn, derived)

1,6302,0533,1313,7632,092

Free cash flow (INR Mn)

5,0779832,439-347373

Investing cash flow (INR Mn)

-1,400-1,468-1,818-3,302-1,898

Financing cash flow (INR Mn)

-1,765-1,936-1,969-2,119-2,277

Dividends declared for the year (INR Mn, derived)

1,6921,6921,6921,8801974

Share buybacks (INR Mn)

00000

Cash taxes paid (INR Mn)

2,2711,7131,0521,2491,051

Returns & Leverage Ratios (%) and Financial Ratios (x)

MetricFY2022FY2023FY2024FY2025FY2026

ROE / ROANW, company (%)

51.4129.6617.9418.3814.23

ROACE, PBIT/avg. capital employed, company (%)

67.3539.1024.1624.8619.45

ROA, PAT/avg. total assets (%, derived)

33.520.212.012.09.5

Interest coverage, PBIT/finance cost (x, derived)

186186664332

Asset turnover, revenue/avg. total assets (x, derived)

2.542.141.831.851.54

Dividend payout, declared/PAT (%, derived)

25.534.048.848.160.3

Financial Ratios (x) and Returns & Leverage Ratios (%)

MetricFY2024FY2025FY2026

Current ratio (x)

2.231.912.02

Debt incl. leases / equity (x)

0.060.060.05

Net debt / total EBITDA (x, negative = net cash)

-1.83-1.26-1.06

ROIC, NOPAT / (equity + leases − liquid assets) (%, derived)

29.023.517.6

Inventory days on total expenses (days)

36.646.646.5

Receivable days on revenue (days)

27.423.834.4

Payable days (days)

61.766.064.0

Cash conversion cycle (days)

2.34.416.9

Region Overview

RegionFY2026

India, domestic share of turnover (%)

91.74

Exports share of turnover (%)

8.26

India domestic revenue (INR Mn, derived)

48,975

Export revenue (INR Mn, derived)

4,409

Share Price History

DatePrice (INR)Market cap (INR Cr)Source

22 Apr 2025

626.85

about 11,787 (derived)

IndMoney

30 Sep 2025

832.3515,652

Q2 FY26 deck

14 Jan 2026

543.85

about 10,227 (derived)

Simply Wall St

30 Jun 2026

714.6513,438

Q1 FY27 deck

28 Aug 2026

692.9513,282

Anand Rathi

18 Sep 2026

809.4015,220

Anand Rathi

25 Sep 2026

879.90

about 16,546 (derived)

Bajaj Finserv

Valuation Multiples

MultipleBasisValue

P/E

TTM to June 2026 standalone EPS ₹25.67 (PAT INR 4,827 Mn)

34.3x

P/E

FY26 EPS ₹17.41

50.5x

P/B

FY26 book value ₹126

7.0x

EV/EBITDA

TTM total EBITDA INR 7,762 Mn; EV INR 156.7 bn (market cap less ₹874 cr surplus)

20.2x

EV/EBITDA

FY26 EBITDA INR 5,581 Mn; EV net of FY26 net cash

28.6x

EV/Sales

TTM revenue INR 56,446 Mn

2.8x

Dividend yield

₹10.50 FY26 DPS

1.19%

Analyst Ratings & Targets

Broker / sourceDateRatingTarget (INR)

KRChoksey (Deven Choksey)

30 Apr 2025

—

684 (18x FY27E EPS)

KRChoksey

29 Apr 2026

—843

KRChoksey

14 Jul 2026

Accumulate

813

Trendlyne consensus

24 Jul 2026

Hold

791.5

AllInvestView consensus

2026—805

Simply Wall St (3 analysts; most bullish)

2026—875

Per-Share Data and Returns & Leverage Ratios (%)

MetricFY2022FY2023FY2024FY2025FY2026

DPS split-adjusted (INR)

9.009.009.0010.0010.50

Payout ratio (%)

25.534.048.848.160.3

Credit Ratings

AgencyLong-termShort-termOutlookDateRated facilities

CRISIL

AA-

A1+

Stable (from Positive)

27 Feb 2026

₹1,900 cr bank facilities

India Ratings

IND AA-

IND A1+

Stable (from Positive)

17 Dec 2025

INR 19,000 Mn bank facilities

Moody's / S&P / Fitch

Not rated

————

Analyst Conclusions

Management guidance.

  • No FY27 volume or margin guidance (Q1 FY27 call, July 2026). Management cited fluid demand, West Asia uncertainty for exports, and SM availability and shipping risks.

  • Management called the Q1 FY27 margin of about 19% an aberration.

  • Demand from non-OEM processors had returned by the end of Q1.

  • Committed capacity additions: SPC to 80 kt, XPS to 122k m³, PS to 380 kt by March 2029, ABS toward 140 kt, and the Karnal greenfield. All are internally funded within an expansion programme of about ₹900 cr.

Marketscreener-type projections exist for peers but not reliably for SPL. Price-target consensus is about ₹790–810 (Trendlyne; AllInvestView). The bullish Simply Wall St cohort assumes about 27% annual revenue growth over three years (an aggressive outlier).

Bull case.

  1. Margin regime shift. Q4 FY26 (16.0%) and Q1 FY27 (19.5%) show earnings power of INR 3,000–3,500 Mn of quarterly EBITDA in a tight-delta world. With Gulf SM capacity impaired, deltas could stay above the CRISIL steady state of about 7%.

  2. ABS and compounds re-rate the mix. Reaching 36 kt of ABS (FY27 target) and then 140 kt, monetised through Xmold and 80 kt of SPC, moves value-added products from about 6% toward 25–30% of manufactured revenue and lowers earnings volatility. Ind-Ra expects a higher through-cycle ABS margin.

  3. Balance-sheet optionality. The ₹874 cr surplus with no debt allows the PS line, Karnal and ABS Phase II to proceed without dilution, while a payout of 50–60% supports yield.

Bear case.

  1. Spread mean-reversion. Management itself calls Q1 an aberration. If deltas normalise as Gulf SM restarts, EBITDA could revert to FY24–FY26 levels (INR 5.3–6.1 bn per year). That would leave the stock at 26–30x EV/EBITDA, above the cycle average.

  2. Execution and volume risk. Volume fell 24.5% in Q1 FY27; ABS has a history of delay and breakdown; and EPS competition is intensifying. FY26 volume growth was only 2% against guidance of about 10%.

  3. Policy and import exposure. The 2026 duty suspension showed how quickly imports (about 87 kt of PS in FY26) can take share. Cash conversion has weakened (FCF of INR −347 Mn in FY25 and INR 373 Mn in FY26), while dividends exceed FCF.

Key catalysts and monitorables (next 12 months).

  • Q2 FY27 results (expected around 23 October 2026): durability of the delta, volume recovery and restart of exports.

  • ABS utilisation against the 36 kt FY27 target, and OEM approvals for ABS compounds.

  • Restoration of Gulf SM supply and Strait of Hormuz shipping.

  • Status of polymer import duties and anti-dumping.

  • Commissioning of SPC (80 kt) and the XPS expansion.

  • Purchase of Xmold's remaining 20% by March 2027.

  • Karnal environmental clearance and project sanction.

  • Interim dividend (October 2026) and capital allocation.

  • Further rating actions (CRISIL or Ind-Ra moving back to Positive).

  • Cooling-appliance season in Q4 FY27 and Q1 FY28.

Concluding analyst verdict.

Supreme Petrochem is a high-quality, conservatively financed franchise in a structurally cyclical business. Its standing as India's dominant styrenics producer is entrenched: more than 50% share, a rival's exit since 2020, the only domestic XPS plant and the first continuous mass-ABS line. Its balance sheet carries no debt and allows it to keep investing through downturns. Those are durable advantages, and they explain why ROACE stayed close to 20% even in the FY26 trough, when revenue fell 11% and the operating margin touched 5.5% in Q3.

The investment debate centres on two questions: whether the 2026 margin spike persists, and whether ABS changes the company's character. The evidence on the first is ambiguous. Q4 FY26 and Q1 FY27 margins were extraordinary, but management attributes them to a temporary global delta caused by the West Asia war, not to structural improvement. Q1 volume fell 24.5%. On the second question, the strategic direction is sound: ABS, compounds via Xmold, XPS and a northern greenfield. The record, however, is mixed so far. ABS ran late, broke down, and has yet to demonstrate commercial utilisation, while FY26 volume growth missed guidance badly.

At about ₹880, the stock trades on about 34x trailing and about 50x FY26 earnings, about 20x trailing EV/EBITDA and 7x book. It sits above every published sell-side target (₹684–875). That price capitalises much of the spike as durable. Our assessment is that the franchise merits a premium to Indian commodity chemicals, but the current valuation leaves little margin of safety if deltas normalise toward CRISIL's steady state of about 7%. We would characterise the shares as fairly to fully valued — Hold. The thesis would turn constructive on demonstrated ABS throughput of at least 3,000 t per month with OEM compound approvals, and on evidence that quarterly operating EBITDA can hold above INR 2,000 Mn without a geopolitical tailwind. It would turn negative on delta collapse combined with continued volume loss to imports.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Executive Leadership Team

NameTitleTenure / backgroundEducationAgeFY2026 remuneration

N. Gopal

Executive Director & Manager (statutory "Manager"; de facto chief executive and chief technologist)

Joined 1990 as Sr. VP (Projects & Operations); about 57 years in petrochemicals. Ex-ICI Petrochemicals (UK), IPCL, Reliance. Built the 66 kt PS plant and every expansion since; leads the Karnal project. Reappointed 20 April 2026 to 31 March 2029

M.Sc., B.Tech (Chem. Eng.), Madras University; DIC (Advanced Chem. Eng.), Imperial College London

Above 70 (per AGM resolution)

₹417.97 lakh (₹4.18 cr). Approved ceiling ₹525 lakh per year plus perquisites. Increment 6.7% in FY26

Rakesh Nayyar

Executive Director & CFO

———

Not individually disclosed in sources reviewed. Median KMP remuneration was ₹3.754 cr (BRSR); CFO increment 6.8%

K. V. Mujumdar

Whole Time Director (Board member; responsible for BRSR/ESG)

DIN 08866096; Amdoshi plant-based leadership

——

Ratio to median employee 21.7:1 (about ₹1.6–1.7 cr implied; derived). Increment 7.6%

D. N. Mishra

AVP & Company Secretary (FCS 5506)

Compliance officer

FCS

—

Not individually disclosed. Increment 11.3%

“—” = not publicly disclosed.

Board of Directors

NameCategoryTenure / roleAgeNotes

M. P. Taparia

Chairperson; Non-Executive, Non-Independent, Promoter

Director since 14 Dec 1989

88

Managing Director, The Supreme Industries Ltd. Sitting fees ₹6 lakh in FY26. Holds 75,466 SPL shares

Rajan B. Raheja

Non-Executive, Non-Independent, Promoter

Long-standing

—

Head of the Rajan Raheja group

S. J. Taparia

Non-Executive, Non-Independent

Since 22 Nov 1993

80

Executive Director, The Supreme Industries. Sitting fees ₹9 lakh. Holds 75,466 shares

Akshay R. Raheja

Non-Executive, Non-Independent

——

Next generation of the Raheja family

K. V. Mujumdar

Whole Time Director

Executive

—

See management table

Rajeev M. Pandia

Independent

Appointed around FY24 (per AR FY24 references)

——

Prof. (Dr.) Anup Kumar Ghosh

Independent

———

Basavaraj N. Bankapur

Independent

Recent appointment

——

Sanjay R. Chougule

Independent

———

Rita A. Teaotia

Independent (woman)

——

Retired senior civil servant (former Union Commerce Secretary)

Mona N. Desai

Independent (woman)

Recent appointment

——

B. L. Taparia

Non-Executive (ceased)

Died 30 Jan 2026

——

“—” = not publicly disclosed.

Major Shareholders

Holder categoryStake

Promoters & promoter group

64.24%

Domestic institutions (mostly mutual funds)

4.14%

FPIs / FIIs

3.80%

Public and others

27.82%

Major Shareholders by Rank

RankHolderStakeSource / date
1

The Supreme Industries Ltd (promoter)

30.78% (57,872,800 shares)

Exchange SHP via Bajaj Finserv; CRISIL (Dec 2025)

2

R Raheja Investments Pvt Ltd (promoter)

30.78% (57,872,800 shares)

Same

3

Investor Education & Protection Fund (IEPF)

1.99%

Simply Wall St

4

HSBC Small Cap Fund (HSBC Mutual Fund)

1.70% (3,198,370 shares)

Exchange SHP (Mar 2026)

5

Hathway Investments Pvt Ltd

1.51%

Simply Wall St

6

The Vanguard Group

1.11%

Simply Wall St

7

Dimensional Fund Advisors

0.58%

Simply Wall St

8

ICICI Prudential AMC

0.51%

Simply Wall St

9–10

Other institutions

——

Competitive Landscape

Competitors by Segment

SegmentCompetitorTypePositioning versus SPL

PS (GPPS/HIPS)

Styrenix Performance Materials Ltd (formerly INEOS Styrolution India)

Domestic listed

Second domestic styrenics producer; broader ABS and specialty portfolio

PS

LG Polymers India (Visakhapatnam)

Domestic (idle)

Plant shut since the 2020 styrene leak; removed a major rival (CRISIL: second-largest player shut in FY21)

PS imports

Producers in Thailand, South Korea, Taiwan, Iran and Singapore (CRISIL), e.g., INEOS Styrolution, Chi Mei, LG Chem, Formosa, TotalEnergies

Import competition

About 87 kt imported in FY26; surge in Q1 FY27 during the duty suspension; anti-dumping duties used historically

EPS

EPACK group (EPS beads) and other new domestic entrants

Domestic

Capacity additions in FY25 (KRChoksey); price competition in a fragmented moulder market

EPS imports

Asian EPS bead producers

Import

Price-setting at the margin

ABS

Styrenix Performance Materials

Domestic listed

Incumbent largest Indian ABS producer (emulsion process) with ASA, PC/ABS and SAN

ABS

Bhansali Engineering Polymers Ltd

Domestic listed

—

ABS imports

LG Chem, Chi Mei, Lotte Chemical, Formosa and others

Import

Bulk of Indian ABS demand historically imported

Compounds and masterbatches

Kingfa Science & Technology (India), Plastiblends India, Avient and others

Domestic / MNC

Fragmented market; SPL's edge is captive base polymers and OEM relationships

XPS

Imported XPS brands; PIR/PUF and mineral-wool alternatives

Import / substitutes

SPL is the only domestic XPS producer

Peer Comparison FY2026

MetricSupreme Petrochem (standalone)Styrenix Performance Materials (consolidated)

Revenue (INR Mn)

53,38434,380

Revenue growth YoY (%)

-11.415.3

EBITDA margin (%)

10.45 (total) / 9.64 (operating)

10.4 (company); 9.98 (Stock Analysis)

PAT (INR Mn)

3,2731,828

Net margin (%)

6.135.3

R&D intensity (%)

0 (statutory)

—

Net debt

Net cash

Net debt (interest cost INR 194.5 Mn)

“—” = not publicly disclosed.

Recent Developments

The Q1 FY27 earnings-call date is reported as 29 July 2026 in the scheduling intimation; one aggregator cites 27 July.

Company Snapshot

$616.4M

Revenue

444

Employees

1989

Founded

SWOT Analysis

Strengths

  • Dominant share: more than 50% of Indian PS and EPS, with the largest installed capacity; the second-largest rival's plant has been shut since FY2021 (CRISIL, February 2026).
  • Balance sheet: zero borrowings at 31 March 2026 (AR FY26), investable surplus of ₹874 cr at June 2026, and CRISIL and Ind-Ra AA- ratings.
  • Self-funded growth: ABS (about ₹850 cr), EPS II, SPC and the new ₹325 cr PS line are all funded internally, and the payout ratio was still about 60% in FY26.
  • Unique assets: India's only XPS plant and first continuous mass-ABS line (Q1 FY27 deck).
  • Operational safety and ESG discipline: zero LTIFR and zero fatalities in FY25–FY26; 9,295 accident-free days at Amdoshi; zero liquid discharge at both plants; about 50% renewable power; BRSR Core with reasonable assurance (BRSR FY26).
  • Cycle resilience: ROACE of 19.45% even at the FY26 trough, with operating EBITDA positive in every quarter (AR FY26).

Weaknesses

  • Raw-material dependence: 100% imported SM; foreign-exchange outflow of ₹3,959 cr in FY26 versus inflow of ₹458 cr (AR FY26).
  • Commodity mix: PS and EPS were 71% and traded SM 23% of FY25 revenue; value-added products only 6% (CRISIL).
  • Execution: ABS commissioned six months late, then halted after an equipment failure in December 2025 (CRISIL; Ind-Ra).
  • Statutory R&D spend nil in FY26 (AR FY26). No patent portfolio has been disclosed.
  • Weakening cash conversion: FCF of INR −347 Mn (FY25) and INR 373 Mn (FY26), and a CCC widening from 2 to 17 days (derived).
  • Key-person and board-age concentration: Chair aged 88, director aged 80, and the de facto CEO over 70 and reappointed to 2029 (AGM Notice FY26).

Opportunities

  • ABS import substitution: a 140 kt terminal capacity, a FY27 target of about 36 kt, and an Ind-Ra view of a higher through-cycle ABS margin.
  • Southern auto and appliance clusters through Xmold (15 kt compounding; Tier-II OEM access), with SPC capacity rising to 80 kt (Q1 FY27 deck).
  • Building energy efficiency: XPS capacity rising 69% (72k→122k m³).
  • Northern market proximity: Karnal greenfield (96 acres; about 387 kt potential capacity per Ind-Ra).
  • Low appliance penetration in India plus localisation policy support, a structural tailwind for HIPS and ABS demand (qualitative; company end-market commentary).
  • Circular economy: an established EPR compliance framework and ICPE recycling partnerships position SPL for tighter plastic rules (BRSR FY26).

Threats

  • SM supply security: all three Gulf SM plants supplying SPL shut during the 2026 West Asia war (Q1 FY27 deck).
  • Policy: suspension of polymer import duties in 2026 let imports take local share (Q1 FY27 deck), and the anti-dumping regime could change.
  • Asian oversupply: dumping by Thailand, Korea, Taiwan, Iran and Singapore cited by CRISIL; about 87 kt of PS imports in FY26.
  • New domestic EPS capacity (Styrenix, EPACK) eroding share (KRChoksey FY25).
  • Spread mean-reversion: management calls the Q1 FY27 margin of about 19% an aberration, and CRISIL's steady-state margin is about 7%.
  • Weather and seasonality: unseasonal rains and mild summers cut FY26 volume growth to 2% (AR FY26).

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
10 Apr 2025SPA signed with Xmold Polymers' shareholders ScanX; AR FY26First acquisition in company history
17 Apr 202580% of Xmold acquired; subsidiary formed ScanXConsolidated reporting begins FY26
23 Apr 2025Q4 FY25 results: revenue about ₹1,539 cr; PAT ₹106.9 cr (−19% YoY); final dividend ₹7.50 recommended Reuters; ArihantFY25 PAT ₹390.5 cr (+12.7%)
30 Apr 2025KRChoksey target ₹684 (18x FY27E EPS); expects 20–25 kt of ABS volume in FY26Cautious sell-side tone
Jun 2025FY25 Annual Report and 36th AGM notice filed Exchange filing (9 Jun 2025)—
4 Jul 2025Record date for ₹7.50 final dividend Dividend records—
23 Jul 2025Q1 FY26 results: PAT ₹80.9 cr (vs ₹122 cr) on revenue of ₹1,386.5 cr; volume roughly flat Corporate actions; SahiWeak domestic demand
25 Sep 2025First 70 kt mass-ABS line commissioned at Amdoshi with Versalis assistance Exchange filingKey strategic milestone, six months late
24 Oct 2025Q2 FY26 results: revenue INR 11,002 Mn (−26.9%); PAT INR 482 Mn (−46.6%); interim dividend ₹2.50 Q2 FY26 deckMonsoon, GST-cut deferral, tariffs, destocking; SM about US$800/t
24 Oct 2025Q2 FY26 deck: 52-week high ₹981.65 earlier in the cycle; market cap about ₹15,652 cr at 30 Sep 2025—
9 Dec 2025Manali plant operations restored after disruption Reuters summaryOperational continuity
Dec 2025ABS operations suspended after failure of proprietary critical equipment CRISIL; BRSRDelays value-added mix; insured and under warranty
17 Dec 2025India Ratings revises outlook from Positive to Stable (IND AA-) Ind-Ra; FilingReaderCites weak 1HFY26, ABS delay, net debt including acceptances
20 Jan 2026Q3 FY26 results: standalone PAT about ₹30 cr; operating margin 5.47% Kotak Neo; ArthneetiCycle trough
30 Jan 2026Death of director B.L. Taparia AR FY26Board reduces to 11
Feb 2026ABS production restarted through an alternate arrangement BRSR FY26Partial recovery
27 Feb 2026CRISIL revises outlook from Positive to Stable; AA- and A1+ reaffirmedMargin moderation; ABS ramp-up delay
6 Mar 2026ABS partially restored at about 65% capacity (trade report) Sahi—
Mar 2026West Asia war: Gulf SM plants shut; exports negligible in March AR FY26; Q1 FY27 deckSupply-chain shock; deltas widen
24 Apr 2026Q4 FY26 results: PAT ₹168.0 cr (+57%); EBITDA margin 16.5%; volume +5.4%; final dividend ₹8 Arihant; CholaSharp earnings inflection
20 Apr 2026N. Gopal reappointed Manager to March 2029 (subject to AGM) AGM NoticeLeadership continuity; key-person concentration
17 Jun 2026FY26 Annual Report and BRSR (with BRSR Core reasonable assurance) filed Exchange filingsClean audit; zero LTIFR
1 Jul 2026CRISIL ESG Ratings assigns an ESG rating (score not disclosed in sources reviewed) SahiESG coverage initiated
14 Jul 202637th AGM (virtual) approves accounts, dividend and reappointments AGM Notice; Sahi—
14 Jul 2026KRChoksey "Accumulate", target ₹813 Trendlyne—
27 Jul 2026Q1 FY27 results: revenue INR 16,927 Mn (+22%); PAT INR 2,363 Mn (+192%); operating margin 19.53%; volume −24.5% Q1 FY27 deckRecord profit on spread spike
27 Jul 2026Board approves 80 kt PS line (₹325 cr; by March 2029); EPS Phase II complete; XPS and SPC expansions started Q1 FY27 deckCapacity growth continues
29 Jul 2026Q1 FY27 call: no FY27 guidance; FY26 PS imports about 87 kt; duty suspension spurred imports; SM about US$1,300/t CIF Sahi; CompoundingAIVisibility constrained
6 Aug 2026Investor meeting held (intimation filed) 5paisa (exchange feed)IR engagement
Sep 2026Share price rallies from about ₹693 (28 Aug) to about ₹880 (25 Sep) Anand Rathi; Bajaj FinservRe-rating on margin durability hopes
c. 23 Oct 2026 (expected)Q2 FY27 results (estimated date) AllInvestView (estimate)Next catalyst

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

6 charts
Income Statement: Revenue & Gross Profit: Revenue from operations rose from INR 50,323 Mn in FY2022 to INR 53,384 Mn in FY2026.
Supreme Petrochem Ltd. — Income Statement: Revenue & Gross Profit
Series (INR Mn)FY2022FY2023FY2024FY2025FY2026
Revenue from operations50,32352,87252,53360,23453,384
Gross profit, aggregator basis11,8419,8468,0638,9079,307

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.